Aspen Aerogels (NYSE:ASPN) Given New $13.00 Price Target at Barclays

Aspen Aerogels (NYSE:ASPN) had its price objective cut by Barclays from $25.00 to $13.00 in a research note published on Wednesday,Benzinga reports. They currently have an overweight rating on the construction company’s stock.

Several other research analysts have also recently issued reports on the stock. Roth Mkm decreased their target price on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a report on Friday, February 14th. Piper Sandler decreased their target price on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. Craig Hallum decreased their target price on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a report on Friday, February 14th. Canaccord Genuity Group decreased their target price on shares of Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a report on Friday, February 14th. Finally, StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $22.44.

Aspen Aerogels Trading Down 1.4 %

NYSE:ASPN opened at $8.04 on Wednesday. Aspen Aerogels has a one year low of $7.96 and a one year high of $33.15. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. The company’s 50-day simple moving average is $11.75 and its 200 day simple moving average is $18.15. The firm has a market capitalization of $659.27 million, a P/E ratio of 50.22 and a beta of 2.14.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. As a group, analysts forecast that Aspen Aerogels will post 0.22 EPS for the current fiscal year.

Institutional Trading of Aspen Aerogels

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Lord Abbett & CO. LLC purchased a new stake in Aspen Aerogels during the third quarter valued at approximately $10,126,000. Oppenheimer & Co. Inc. increased its holdings in Aspen Aerogels by 167.2% during the third quarter. Oppenheimer & Co. Inc. now owns 102,535 shares of the construction company’s stock valued at $2,839,000 after buying an additional 64,154 shares during the last quarter. Sanders Morris Harris LLC increased its holdings in Aspen Aerogels by 337.5% during the fourth quarter. Sanders Morris Harris LLC now owns 35,000 shares of the construction company’s stock valued at $436,000 after buying an additional 27,000 shares during the last quarter. Penserra Capital Management LLC purchased a new stake in Aspen Aerogels during the third quarter valued at approximately $1,342,000. Finally, Geode Capital Management LLC increased its holdings in Aspen Aerogels by 5.7% during the third quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company’s stock valued at $38,385,000 after buying an additional 75,024 shares during the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.